Milestone Pharmaceuticals

$6.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.48 (-6.90%) As of 6:43 PM UTC today

Why Robinhood?

You can buy or sell MIST and other stocks, options, and ETFs commission-free!

About MIST

Milestone Pharmaceuticals Inc. Common Shares, also called Milestone Pharmaceuticals, is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada. The listed name for MIST is Milestone Pharmaceuticals Inc. Common Shares.

CEO
Joseph G. Oliveto
Employees
30
Headquarters
Montréal, Québec
Founded
2005
Market Cap
183.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
84.18K
High Today
$7.17
Low Today
$6.29
Open Price
$7.01
Volume
221.98K
52 Week High
$20.75
52 Week Low
$1.69

MIST Earnings

-$1.04
-$0.69
-$0.35
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

DECK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure